- Home
- RRR vs NOVT Comparison
RRR vs NOVT Comparison
Compare RRR & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RRR | NOVT |
|---|---|---|
| Founded | 1976 | 1968 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Hotels/Resorts | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.4B |
| IPO Year | 2015 | 1999 |
Fundamental Metrics
Financial Performance| Metric | RRR | NOVT |
|---|---|---|
| Price | $56.03 | $125.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 1 |
| Target Price | $68.57 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 850.2K | 319.0K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.62% | N/A |
| EPS Growth | ★ 23.32 | N/A |
| EPS | ★ 3.12 | 1.47 |
| Revenue | ★ $2,011,483,000.00 | $521,290,000.00 |
| Revenue This Year | $3.46 | $8.71 |
| Revenue Next Year | $4.61 | $6.47 |
| P/E Ratio | ★ $18.06 | $83.96 |
| Revenue Growth | 3.74 | ★ 35.49 |
| 52 Week Low | $39.45 | $98.27 |
| 52 Week High | $68.99 | $149.95 |
Technical Indicators
Market Signals| Indicator | RRR | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 54.44 |
| Support Level | $55.56 | $111.73 |
| Resistance Level | $61.44 | $129.50 |
| Average True Range (ATR) | 2.02 | 4.64 |
| MACD | 0.26 | 1.55 |
| Stochastic Oscillator | 49.33 | 92.69 |
Price Performance
Historical ComparisonAbout RRR Red Rock Resorts Inc.
Red Rock Resorts Inc along with its subsidiary is a gaming, development and management company that develops and operates strategically-located casino and entertainment properties. Its casino properties are conveniently located throughout the Las Vegas valley and provide its customers a wide variety of entertainment and dining options. The majority of revenue is derived from Casinos.
About NOVT Novanta Inc.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.